Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes. Clinics [Internet]. 2022 Mar. 15 [cited 2024 May 20];76:e2587. Available from: https://revistas.usp.br/clinics/article/view/191921